Back
YieldMax AAPL Option Income Strategy ETF Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
41
APLY
YieldMax AAPL Option Income Strategy ETF
Last Price:
$13.45
Seasonality Move:
-15.5%
Sell
32
NONOF
Novo Nordisk A/S
Last Price:
$48.00
Seasonality Move:
3.42%
Sell
41
YieldMax AAPL Option Income Strategy ETF (APLY)
is a Sell
Is YieldMax AAPL Option Income Strategy ETF a Buy, Sell or Hold?
-
The current YieldMax AAPL Option Income Strategy ETF [APLY] share price is $13.40. The Score for APLY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
APLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $48.00. The Score for NONOF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLY Stock Price Chart
What is YieldMax AAPL Option Income Strategy ETF's stock price today?
-
The YieldMax AAPL Option Income Strategy ETF share price today is $13.40Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLY is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $48.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
APLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 37.96 | Sell |
| Chaikin Money Flow: | 89232 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.52 - 13.92) | Sell |
| Bollinger Bands (100): | (13.19 - 13.89) | Sell |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 47.42 | Sell |
| Chaikin Money Flow: | 54114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.71 - 49.05) | Buy |
| Bollinger Bands (100): | (47.98 - 57.06) | Sell |
APLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.56 | Sell |
| 20-day SMA: | 13.74 | Sell |
| 50-day SMA: | 13.7 | Sell |
| 200-day SMA: | 13.53 | Sell |
| 8-day EMA: | 13.53 | Sell |
| 20-day EMA: | 13.65 | Sell |
| 50-day EMA: | 13.67 | Sell |
| 200-day EMA: | 14.08 | Sell |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.81 | Sell |
| 20-day SMA: | 47.97 | Buy |
| 50-day SMA: | 50.02 | Sell |
| 200-day SMA: | 60.74 | Sell |
| 8-day EMA: | 48.35 | Sell |
| 20-day EMA: | 48.4 | Sell |
| 50-day EMA: | 50.13 | Sell |
| 200-day EMA: | 63 | Sell |
YieldMax AAPL Option Income Strategy ETF Earnings Growth & APLY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
YieldMax AAPL Option Income Strategy ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||